Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Enlargement of the WHO international repository for platelet transfusion-relevant bacteria reference strains.

Spindler-Raffel E, Benjamin RJ, McDonald CP, Ramirez-Arcos S, Aplin K, Bekeredjian-Ding I, de Korte D, Gabriel C, Gathof B, Hanschmann KM, Hourfar K, Ingram C, Jacobs MR, Keil SD, Kou Y, Lambrecht B, Marcelis J, Mukhtar Z, Nagumo H, Niekerk T, Rojo J, Marschner S, Satake M, Seltsam A, Seifried E, Sharafat S, Störmer M, Süßner S, Wagner SJ, Yomtovian R; ISBT Working Party Transfusion-Transmitted Infectious Diseases (WP-TTID), Subgroup on Bacteria.

Vox Sang. 2017 Nov;112(8):713-722. doi: 10.1111/vox.12548. Epub 2017 Sep 27.

PMID:
28960367
2.

Inactivation of Middle East respiratory syndrome coronavirus (MERS-CoV) in plasma products using a riboflavin-based and ultraviolet light-based photochemical treatment.

Keil SD, Bowen R, Marschner S.

Transfusion. 2016 Dec;56(12):2948-2952. doi: 10.1111/trf.13860. Epub 2016 Nov 2.

PMID:
27805261
3.

Riboflavin and ultraviolet light: impact on dengue virus infectivity.

Faddy HM, Fryk JJ, Watterson D, Young PR, Modhiran N, Muller DA, Keil SD, Goodrich RP, Marks DC.

Vox Sang. 2016 Oct;111(3):235-241. doi: 10.1111/vox.12414. Epub 2016 Jun 9.

PMID:
27281512
4.

Evaluation of Mirasol pathogen reduction system by artificially contaminating platelet concentrates with Staphylococcus epidermidis: A pilot study from India.

Chatterjee K, Zaman S, Chaurasia R, Singh S, Keil SD, Tewari S, Bisht A, Agarwal N, Rout D, Chand S, Saha K.

Asian J Transfus Sci. 2016 Jul-Dec;10(2):127-31. doi: 10.4103/0973-6247.187946.

5.

Treatment of blood with a pathogen reduction technology using ultraviolet light and riboflavin inactivates Ebola virus in vitro.

Cap AP, Pidcoke HF, Keil SD, Staples HM, Anantpadma M, Carrion R Jr, Davey RA, Frazer-Abel A, Taylor AL, Gonzales R, Patterson JL, Goodrich RP.

Transfusion. 2016 Mar;56 Suppl 1:S6-15. doi: 10.1111/trf.13393.

6.

Treatment of Platelet Products with Riboflavin and UV Light: Effectiveness Against High Titer Bacterial Contamination.

Keil SD, Hovenga N, Gilmour D, Marschner S, Goodrich R.

J Vis Exp. 2015 Aug 24;(102):e52820. doi: 10.3791/52820.

7.

Inactivation of viruses in platelet and plasma products using a riboflavin-and-UV-based photochemical treatment.

Keil SD, Bengrine A, Bowen R, Marschner S, Hovenga N, Rouse L, Gilmour D, Duverlie G, Goodrich RP.

Transfusion. 2015 Jul;55(7):1736-44. doi: 10.1111/trf.13030. Epub 2015 Mar 3.

PMID:
25731607
8.

Riboflavin and ultraviolet light for pathogen reduction of murine cytomegalovirus in blood products.

Keil SD, Saakadze N, Bowen R, Newman JL, Karatela S, Gordy P, Marschner S, Roback J, Hillyer CD.

Transfusion. 2015 Apr;55(4):858-63. doi: 10.1111/trf.12945. Epub 2014 Dec 1.

PMID:
25438832
9.

Treatment of Whole Blood With Riboflavin and UV Light: Impact on Malaria Parasite Viability and Whole Blood Storage.

Owusu-Ofori S, Kusi J, Owusu-Ofori A, Freimanis G, Olver C, Martinez CR, Wilkinson S, Mundt JM, Keil SD, Goodrich RP, Allain JP.

Shock. 2015 Aug;44 Suppl 1:33-8. doi: 10.1097/SHK.0000000000000280.

10.

The effect of riboflavin and ultraviolet light on the infectivity of arboviruses.

Faddy HM, Prow NA, Fryk JJ, Hall RA, Keil SD, Goodrich RP, Marks DC.

Transfusion. 2015 Apr;55(4):824-31. doi: 10.1111/trf.12899. Epub 2014 Nov 5.

PMID:
25370822
11.

Reduction of Leishmania donovani infectivity in whole blood using riboflavin and ultraviolet light.

Tonnetti L, Thorp AM, Reddy HL, Keil SD, Doane SK, Goodrich RP, Leiby DA.

Transfusion. 2015 Feb;55(2):326-9. doi: 10.1111/trf.12820. Epub 2014 Aug 25.

PMID:
25156473
12.

Development of a riboflavin and ultraviolet light-based device to treat whole blood.

Reddy HL, Doane SK, Keil SD, Marschner S, Goodrich RP.

Transfusion. 2013 Jan;53 Suppl 1:131S-136S. doi: 10.1111/trf.12047. Erratum in: Transfusion. 2014 Nov;54(11):3020.

PMID:
23301965
13.

Inactivation of Plasmodium spp. in plasma and platelet concentrates using riboflavin and ultraviolet light.

Keil SD, Kiser P, Sullivan JJ, Kong AS, Reddy HL, Avery A, Goodrich RP.

Transfusion. 2013 Oct;53(10):2278-86. doi: 10.1111/trf.12079. Epub 2013 Jan 16.

PMID:
23320495
14.

Riboflavin and ultraviolet light reduce the infectivity of Babesia microti in whole blood.

Tonnetti L, Thorp AM, Reddy HL, Keil SD, Goodrich RP, Leiby DA.

Transfusion. 2013 Apr;53(4):860-7. doi: 10.1111/j.1537-2995.2012.03791.x. Epub 2012 Jul 13.

PMID:
22803831
15.

Photochemical inactivation of chikungunya virus in plasma and platelets using the Mirasol pathogen reduction technology system.

Vanlandingham DL, Keil SD, Horne KM, Pyles R, Goodrich RP, Higgs S.

Transfusion. 2013 Feb;53(2):284-90. doi: 10.1111/j.1537-2995.2012.03717.x. Epub 2012 May 25.

PMID:
22626525
16.

Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy.

DeNardo DG, Brennan DJ, Rexhepaj E, Ruffell B, Shiao SL, Madden SF, Gallagher WM, Wadhwani N, Keil SD, Junaid SA, Rugo HS, Hwang ES, Jirström K, West BL, Coussens LM.

Cancer Discov. 2011 Jun;1(1):54-67. doi: 10.1158/2159-8274.CD-10-0028. Epub 2011 Jun 1.

17.

Evaluating pathogen reduction of Trypanosoma cruzi with riboflavin and ultraviolet light for whole blood.

Tonnetti L, Thorp AM, Reddy HL, Keil SD, Goodrich RP, Leiby DA.

Transfusion. 2012 Feb;52(2):409-16. doi: 10.1111/j.1537-2995.2011.03285.x. Epub 2011 Aug 9.

PMID:
21827502
18.

A laboratory comparison of pathogen reduction technology treatment and culture of platelet products for addressing bacterial contamination concerns.

Goodrich RP, Gilmour D, Hovenga N, Keil SD.

Transfusion. 2009 Jun;49(6):1205-16. doi: 10.1111/j.1537-2995.2009.02126.x. Epub 2009 Mar 20.

PMID:
19320867
19.

Pathogen reduction of buffy coat platelet concentrates using riboflavin and light: comparisons with pathogen-reduction technology-treated apheresis platelet products.

Li J, de Korte D, Woolum MD, Ruane PH, Keil SD, Lockerbie O, McLean R, Goodrich RP.

Vox Sang. 2004 Aug;87(2):82-90.

PMID:
15355498
20.

Riboflavin and UV-light based pathogen reduction: extent and consequence of DNA damage at the molecular level.

Kumar V, Lockerbie O, Keil SD, Ruane PH, Platz MS, Martin CB, Ravanat JL, Cadet J, Goodrich RP.

Photochem Photobiol. 2004 Jul-Aug;80:15-21.

PMID:
15339215
21.

Photochemical inactivation of selected viruses and bacteria in platelet concentrates using riboflavin and light.

Ruane PH, Edrich R, Gampp D, Keil SD, Leonard RL, Goodrich RP.

Transfusion. 2004 Jun;44(6):877-85.

PMID:
15157255

Supplemental Content

Support Center